CJC 1295 ( without DAC)

CJC-1295 (Without DAC) – Research Peptide (5mg Lyophilised Powder)

CJC-1295 (without DAC) is a synthetic tetrasubstituted peptide analogue of growth hormone–releasing hormone (GHRH). It is supplied as a lyophilised white to off-white powder in a 5mg vial. Each batch is analysed and verified to a purity of ≥99% (HPLC tested). Every vial is batch-coded for full traceability, and a Certificate of Analysis (COA) and Safety Data Sheet (SDS) are available upon request.

This compound is intended exclusively for professional laboratory research. It may be used in in-vitro studies or regulated in-vivo experimental work conducted in accordance with institutional and national research guidelines. CJC-1295 (without DAC) is not intended for human or veterinary use, consumption, or for any diagnostic, therapeutic, or cosmetic purpose. It has not been evaluated or approved by the Medicines and Healthcare products Regulatory Agency (MHRA) or any other regulatory authority for clinical or aesthetic use.

Specifications

• Purity: ≥99% (HPLC verified)
• Form: Lyophilised powder
• Quantity: 5mg per vial
• Variant: Without DAC (Drug Affinity Complex)
• Storage: Store at –20°C, protected from light and moisture
• Shelf Life: 24 months (unopened, under recommended conditions)

Disclaimer
For laboratory research use only. Not intended for human or veterinary administration or consumption. All handling and use must comply with applicable local laws, institutional policies, and standard laboratory safety procedures.